Surgical treatment for pancreatic cancer depends on the tumour’s location and extent, its relationship with nearby blood vessels, and the patient’s overall health. This article explains how these factors influence surgical options and eligibility, while also covering potential risks, recovery, pancreatic function, specialist expertise, treatment planning, and arrangements for international patients.
Details →
Pancreatic cancer diagnosis usually involves several tests, with each providing different information. This article explains how blood tests, CA 19-9, CT, abdominal ultrasound, MRI with MRCP, endoscopic ultrasound, and biopsy are used to investigate suspicious findings. It also explains what each test can show, when further testing may be needed, and how doctors use the results to confirm the diagnosis and assess the extent of the disease before treatment planning.
Details →
Pancreatic cancer includes several tumour types that differ in their cells of origin, biological characteristics, and clinical behaviour. The main types include pancreatic ductal adenocarcinoma (PDAC), neuroendocrine tumours, rare exocrine cancers, and other uncommon pancreatic tumours. Benign, premalignant, cystic, and inflammatory pancreatic lesions can also resemble cancer, making accurate tumour classification important for understanding the diagnosis and planning appropriate clinical management.
Details →
Stage 4 pancreatic cancer is the most advanced stage of the disease, where the cancer has spread beyond the pancreas to distant organs. Stage 4 pancreatic cancer treatment in Germany includes personalised care with chemotherapy, targeted therapy, immunotherapy for eligible patients, dendritic cell therapy, and TACE where appropriate. This article explains survival rates, treatment options, costs, and what patients can expect from specialised cancer centres.
Details →
Explore NanoKnife pancreatic cancer treatment in Germany, including procedure details, cost, advanced diagnostics, and coordinated treatment for international patients through TIG.
Details →
Stage 4 pancreatic cancer treatment in Germany includes TACE and dendritic cell immunotherapy, with expert care from Prof. Vogl and Prof. Gansauge.
Details →
Pancreatic cancer treatment in Germany with dendritic cell therapy by Prof. Dr. Gansauge provides personalized options for advanced or inoperable cases.
Details →
Explore treatment options for pancreatic cancer with liver metastasis in Germany, including TACE treatment and dendritic cell therapy under expert treatment, supported by TIG for international patients.
Details →
Treatment options for stage 4 pancreatic cancer in Germany include TACE and dendritic cell immunotherapy, guided by German specialists with complete support for international patients through TIG.
Details →
Stage 4 pancreatic cancer spreads to distant organs like the liver or lungs. This aggressive disease resists standard treatments such as surgery or systemic chemotherapy.
Details →
German clinics combine innovative options such as TACE therapy and Dendritic Cell Therapy in Germany with standard treatments like surgery, chemotherapy, radiation therapy, and targeted drugs.
Details →
Treatment in Germany combines advanced technology, experienced specialists, and personalized care plans to achieve the best possible outcomes.
Details →
Pancreatic cancer originates in the pancreas, often as ductal adenocarcinoma or as metastases from other cancers. Risk factors include smoking, diabetes, chronic pancreatitis, and genetic predispositions.
Details →
Our benefits:
.webp)
 (1).webp)
.webp)
.jpg)
 (1).webp)
.jpg)